Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study

Introduction: This study was designed to assess the long-term survival of lobectomy, segmentectomy, and wedge resection for pathological stage I non-small cell lung cancer (NSCLC) in patients over 75 years of age.Patients and methods: Pathological stage I NSCLC patients aged ≥75 years who underwent...

Full description

Bibliographic Details
Main Authors: Xining Zhang, Gang Lin, Jian Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2021.652770/full
id doaj-2ab60828afbd4de191eb9658062ede6b
record_format Article
spelling doaj-2ab60828afbd4de191eb9658062ede6b2021-04-15T06:45:24ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2021-04-01810.3389/fsurg.2021.652770652770Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based StudyXining ZhangGang LinJian LiIntroduction: This study was designed to assess the long-term survival of lobectomy, segmentectomy, and wedge resection for pathological stage I non-small cell lung cancer (NSCLC) in patients over 75 years of age.Patients and methods: Pathological stage I NSCLC patients aged ≥75 years who underwent lobectomy, segmentectomy, or wedge resection were identified from the Surveillance, Epidemiology, and End Results database. Propensity score–matched and competing risks analyses were conducted. The overall survival (OS) rate and lung cancer–specific survival (LCSS) rate were compared among the three groups based on the pathological stage.Results: A total of 3,345 patients were included. In the full cohort, the OS rate and LCSS rate of lobectomy were superior to wedge resection, but not to segmentectomy, the OS advantage diminished when patients were over 85 years old or when at least one lymph node was examined during the procedure. Stratified analyses showed that there was no significant difference in OS and LCSS rates among the three surgical procedures for patients with tumors smaller than 1.0 cm. The OS and LCSS of wedge resection, not segmentectomy, were inferior to lobectomy in stage IA2–IB tumors.Conclusion: Lobectomy should be recognized as the “gold standard” procedure for pathological stage I NSCLC in patients over 75 years of age, and segmentectomy could be considered as an effective alternative. Wedge resection could be considered for patients with compromised cardiopulmonary function or tumors smaller than 1.0 cm, and intraoperative lymph node examination should be conducted.https://www.frontiersin.org/articles/10.3389/fsurg.2021.652770/fullelderlylimited resectionlobectomynon-small cell lung cancersurgery
collection DOAJ
language English
format Article
sources DOAJ
author Xining Zhang
Gang Lin
Jian Li
spellingShingle Xining Zhang
Gang Lin
Jian Li
Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
Frontiers in Surgery
elderly
limited resection
lobectomy
non-small cell lung cancer
surgery
author_facet Xining Zhang
Gang Lin
Jian Li
author_sort Xining Zhang
title Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
title_short Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
title_full Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
title_fullStr Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
title_full_unstemmed Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study
title_sort comparative effectiveness of lobectomy, segmentectomy, and wedge resection for pathological stage i non-small cell lung cancer in elderly patients: a population-based study
publisher Frontiers Media S.A.
series Frontiers in Surgery
issn 2296-875X
publishDate 2021-04-01
description Introduction: This study was designed to assess the long-term survival of lobectomy, segmentectomy, and wedge resection for pathological stage I non-small cell lung cancer (NSCLC) in patients over 75 years of age.Patients and methods: Pathological stage I NSCLC patients aged ≥75 years who underwent lobectomy, segmentectomy, or wedge resection were identified from the Surveillance, Epidemiology, and End Results database. Propensity score–matched and competing risks analyses were conducted. The overall survival (OS) rate and lung cancer–specific survival (LCSS) rate were compared among the three groups based on the pathological stage.Results: A total of 3,345 patients were included. In the full cohort, the OS rate and LCSS rate of lobectomy were superior to wedge resection, but not to segmentectomy, the OS advantage diminished when patients were over 85 years old or when at least one lymph node was examined during the procedure. Stratified analyses showed that there was no significant difference in OS and LCSS rates among the three surgical procedures for patients with tumors smaller than 1.0 cm. The OS and LCSS of wedge resection, not segmentectomy, were inferior to lobectomy in stage IA2–IB tumors.Conclusion: Lobectomy should be recognized as the “gold standard” procedure for pathological stage I NSCLC in patients over 75 years of age, and segmentectomy could be considered as an effective alternative. Wedge resection could be considered for patients with compromised cardiopulmonary function or tumors smaller than 1.0 cm, and intraoperative lymph node examination should be conducted.
topic elderly
limited resection
lobectomy
non-small cell lung cancer
surgery
url https://www.frontiersin.org/articles/10.3389/fsurg.2021.652770/full
work_keys_str_mv AT xiningzhang comparativeeffectivenessoflobectomysegmentectomyandwedgeresectionforpathologicalstageinonsmallcelllungcancerinelderlypatientsapopulationbasedstudy
AT ganglin comparativeeffectivenessoflobectomysegmentectomyandwedgeresectionforpathologicalstageinonsmallcelllungcancerinelderlypatientsapopulationbasedstudy
AT jianli comparativeeffectivenessoflobectomysegmentectomyandwedgeresectionforpathologicalstageinonsmallcelllungcancerinelderlypatientsapopulationbasedstudy
_version_ 1721526538774511616